LYEL
UNKNOWNLyell Immunopharma, Inc.
CIK: 0001806952
Last activity: 4 weeks ago
Financial Metrics
As of Dec 31, 2025 (10-K)
Insider Roster (6 total, 6 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
|
ARCH Venture Fund XIII, L.P.
TEN_PERCENT_OWNER
|
1 | 0 | $12.50M |
1,426,528 shares
$36.53M
|
|
ARCH Venture Partners IX, LLC
TEN_PERCENT_OWNER
|
1 | 0 | $12.50M |
1,426,528 shares
$36.53M
|
|
Seely Lynn
President and CEO
|
0 | 2 | -$184K |
74,266 shares
$1.74M
|
|
Bulis Veronica Sanchez
VP, Corporate Controller
|
0 | 3 | -$80K |
15,637 shares
$362K
|
|
Lee Gary K.
Chief Scientific Officer
|
0 | 2 | -$42K |
16,938 shares
$396K
|
|
Hill Stephen J.
Chief Operating Officer
|
0 | 2 | -$31K |
17,795 shares
$416K
|
Recent Transactions
488,090 shares @ $25.61
$12.50M
Mar 6, 2026
488,090 shares @ $25.61
$12.50M
Mar 6, 2026
7,455 shares @ $23.39
$174K
Feb 11, 2026
1,671 shares @ $23.39
$39K
Feb 11, 2026
1,236 shares @ $23.39
$29K
Feb 11, 2026
438 shares @ $23.12
$10K
Feb 10, 2026
254 shares @ $23.12
$6K
Feb 10, 2026
147 shares @ $23.12
$3K
Feb 10, 2026
109 shares @ $23.12
$3K
Feb 10, 2026
936 shares @ $32.32
$30K
Dec 30, 2025
1,136 shares @ $38.67
$44K
Dec 24, 2025
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.